Dasatinib
- Product NDC
- 68001-663
- 11-digit product format
- 680010663
- Labeler code
- 68001
- Product ID
- 68001-663_4c4a021d-a810-26d0-e063-6294a90abd2d
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dasatinib
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- BluePoint Laboratories
- Application
- ANDA217217
- Marketing category
- ANDA
- Marketing start
- 2025-12-01
- Substance
- DASATINIB
- Active strength
- 80 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Kinase Inhibitor [EPC], Protein Kinase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Dasatinib
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DASATINIB | 80 mg/1 |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | RBZ1571X5H |
| Rxcui | 643105, 643107, 643109, 799047, 1045402, 1045406 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| b66e60ef-563e-ddb8-43b4-d625943af44b | Product name | 3 | 20251209 |
| 820d87d5-5779-4353-ae7e-33904df346a1 | Product name | 1 | 20241218 |
| 594e2c86-3079-4e6e-96c9-48f7a8afc78d | Product name | 1 | 20230718 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68001-663-04 | Dasatinib | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 68001-663-04 | EA - Each | 68001-663 | 4cdc1f40-1309-4f85-967f-a8a84b2524ba | 1 | 2025-10-14 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 799047 | dasatinib 100 MG Oral Tablet | PSN | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 1045402 | dasatinib 140 MG Oral Tablet | PSN | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 643105 | dasatinib 20 MG Oral Tablet | PSN | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 643107 | dasatinib 50 MG Oral Tablet | PSN | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 643109 | dasatinib 70 MG Oral Tablet | PSN | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 1045406 | dasatinib 80 MG Oral Tablet | PSN | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 799047 | dasatinib 100 MG Oral Tablet | SCD | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 1045402 | dasatinib 140 MG Oral Tablet | SCD | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 643105 | dasatinib 20 MG Oral Tablet | SCD | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 643107 | dasatinib 50 MG Oral Tablet | SCD | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 643109 | dasatinib 70 MG Oral Tablet | SCD | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
| 1045406 | dasatinib 80 MG Oral Tablet | SCD | 02b04c6f-4ea5-4fcb-bf6d-2631d5ab31e4 | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 68001-663-04 | 68001066304 | 30 TABLET, FILM COATED in 1 BOTTLE (68001-663-04) | 2025-12-01 | No | No | Historical |